Ishwar Super Speciality & Medical Research Hospital Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 04-12-2024
- Paid Up Capital ₹ 2.81 M
as on 04-12-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2011
- Satisfied Charges ₹ 6.89 Cr
as on 04-12-2024
About Ishwar Super Speciality & Medical Research Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.81 M.
The company has closed loans amounting to ₹6.89 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Amol Gadgil, Swati Gadgil, Archana Bhosale, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100MH2010PTC205269
- Company No.
205269
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jul 2010
- Date of AGM
30 Sep 2011
- Date of Balance Sheet
31 Mar 2011
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ishwar Super Speciality & Medical Research Hospital?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amol Gadgil  | Director | 05-Jul-2010 | Current |
| Swati Gadgil | Director | 12-Jul-2010 | Current |
| Archana Bhosale | Director | 05-Jul-2010 | Current |
| Viral Thakkar | Director | 05-Jul-2010 | Current |
Financial Performance of Ishwar Super Speciality & Medical Research Hospital.
Enhance accessibility to Ishwar Super Speciality & Medical Research Hospital's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ishwar Super Speciality & Medical Research Hospital?
Unlock access to Ishwar Super Speciality & Medical Research Hospital's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Nkgsb Co-Operative Bank Ltd Creation Date: 22 Mar 2011 | ₹4.95 Cr | Satisfied |
Nkgsb Co-Operative Bank Ltd Creation Date: 28 Oct 2010 | ₹1.94 Cr | Satisfied |
How Many Employees Work at Ishwar Super Speciality & Medical Research Hospital?
Unlock and access historical data on people associated with Ishwar Super Speciality & Medical Research Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ishwar Super Speciality & Medical Research Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ishwar Super Speciality & Medical Research Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
